Press releases

  2016/11/29 6:15PM
|

Initiation of coverage by Edison Investment Research

→ pdf
  2016/11/16 5:00PM
|

Publication of the second issue of Quantum Genomics' shareholder newsletter - November, 2016

→ pdf
  2016/10/13 6:00PM
|

Quantum Genomics announces 2016 first-half financial results and first nine months business update

→ pdf
  2016/09/29 5:45PM
|

Quantum Genomics reports positive top-line results from Phase IIa trial of QGC001 in hypertension

→ pdf
  2016/09/22 6:00PM
|

Quantum Genomics Announces Conference Call to Review Top-line Results from Phase IIa Study of QGC001 in Hypertension

→ pdf
  2016/09/12 6:00PM
|

Quantum Genomics to announce Phase IIa clinical trial results for high blood pressure on September 29, 2016

→ pdf
  2016/06/30 6:00PM
|

Quantum Genomics Initiates Phase IIa trial for Heart Failure, the second strategic initiative for its BAPAI therapeutic platform

→ pdf
  2016/06/28 6:00PM
|

Quantum Genomics extends its collaboration agreement with its partner in animal health

→ pdf
  2016/06/02 6:00PM
|

Publication of the first issue of Quantum Genomics' shareholder newsletter - June, 2016

→ pdf
  2016/05/31 6:00PM
|

Quantum Genomics symposium at the European Meeting on Hypertension and Cardiovascular Protection

→ pdf
  2016/05/17 6:00PM
|

Quantum Genomics granted two new U.S. patents covering lead product QGC001

→ pdf
  2016/04/26 6:00PM
|

Regulatory authorisations received in France to begin Phase IIa multicentric European trial for heart failure

→ pdf
  2016/04/14 6:00PM
|

2015 annual report : acceleration of clinical trials, secured financing and internationalisation in progress

→ pdf
  2016/03/24 07:30AM
|

Quantum Genomics Raises EUR 8.6 Million in U.S. and Europe

→ pdf
  2016/03/17 07:30AM
|

2016/03/17 - Quantum Genomics raises EUR 5.54m via private placement in the United States and launches a capital increase amounting to EUR 2.94m

→ pdf
  2016/02/03 6:30PM
|

Quantum Genomics Expands U.S. Presence to Advance its Development Programs for Cardiovascular Diseases

→ pdf
  2016/01/20 6:00PM
|

Enhancement of Quantum Genomics' intellectual property

→ pdf
  2016/01/05 6:00PM
|

Patient enrolment 100% completed for Phase IIa trial for high blood pressure

→ pdf

Each PDF has been scanned by antimalware and incorporates a SECURITY MASTER Footprint. To check its authenticity:
www.security-master-footprint.com

Party powered automatically by Actusnews Wire ©
(Primary Information Provider)